首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1606550

全球骨科手術機器人市場 - 2024-2031

Global Orthopedic Surgical Robots Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球骨科手術機器人市場規模達70億美元，預計2031年將達到107億美元，2024-2031年預測期間複合年成長率為5.7%。

骨科手術機器人確實是骨科手術領域的革命性進步，造福病患。骨科手術機器人透過提供高精度、高效率和侵入性的手術，標誌著骨科手術的顯著進步，並在改善患者治療效果方面具有令人難以置信的優勢。這些機器人以無與倫比的準確性幫助外科醫生執行複雜的手術，而不會因人為錯誤而降低利潤。

由於先進的成像技術、機械手臂和高階軟體，它們還為骨切割以及精確的植體放置和對齊提供即時指導。常用手術的例子包括全關節置換、脊椎手術和骨折修復。現在，所有骨科手術機器人都可以透過最小化軟組織損傷和最佳化工作流程來移動患者，以實現更快的康復、更少的併發症和更大的手術成功率。

市場動態：

驅動程式和限制

骨科疾病盛行率上升

骨關節炎、類風濕性關節炎和骨質疏鬆症等骨科疾病發生率的激增，實際上推動了全球骨科手術機器人市場的發展。這些情況與人口的年齡結構或久坐的生活方式無關；它們直接創造了對關節置換和其他骨科干預措施的需求。

使用骨科機器人的實踐重點是在膝關節手術中提供精確度和結果，而膝關節手術需要滿足大部分要求。機器人替代方案對患者和提供者都有利，因為它們提供更好或改進的對準、更短的恢復時間和更少的併發症。人們越來越依賴機器人協助來減輕日益增加的骨科疾病負擔，從而在全球市場上獲得更廣泛的足跡。

例如，根據澳洲健康與福利研究所2024年的數據，2023年，肌肉骨骼疾病組佔總疾病負擔的12.8%，佔非致命負擔的23.1%，佔致命負擔的0.8%。它是繼精神健康狀況和藥物濫用障礙之後造成非致命負擔的第二大疾病組。背部問題是非致命負擔的主要原因，佔 YLD 的 7.9%。在肌肉骨骼疾病組中，背部問題佔負擔的 34%，其次是其他肌肉骨骼疾病，佔 30%，骨關節炎佔 20%，類風濕性關節炎佔 16%。

機器人成本高

全球骨科手術機器人市場是由這些先進系統的高成本決定的，其成本可能在 5,500 美元到 10,000 美元以上。這些系統具有精確性、縮短恢復時間和改善手術效果，但實施起來成本高昂，特別是在小型醫院和發展中地區。然而，這種財務障礙提供了創新的機會，例如開發具有成本效益的機器人系統或靈活的融資模式，這可以擴大進入並推動市場成長。

Orthopedic surgical robots are indeed revolutionary advances in the field of orthopedic surgery for the benefit of patients. Orthopedic surgical robots mark a considerable improvement in orthopedic surgery by providing surgery with high precision, effectiveness and invasiveness and has incredible advantages to improve patient outcomes. These robots help surgeons with unparalleled accuracy commit to intricate procedures without bringing the margin down due to human error.

They also provide real-time guidance for bone cutting and precise implant placement and alignment, thanks to advanced imaging technologies, robotic arms, and high-end software. Examples of commonly used procedures include total joint replacement, spine surgery, and fracture repairs. All orthopaedic surgical robots through minimal soft tissue damage and optimized workflow can now move a patient for faster recuperation, fewer complications, and greater surgical success.

Market Dynamics: Drivers & Restraints

Rise in the Prevalence of Orthopedic Disorders

The upsurge in the incidence of orthopedic conditions, such as osteoarthritis, rheumatoid arthritis, and osteoporosis, actually drives the global orthopedic surgical robots market. Little do these conditions depend on the age structure or sedentary lifestyle of the population; they directly create demand for joint replacements and other orthopedic interventions.

The practice of using orthopedic robots is focusing on giving precision and outcomes in knee surgeries, where most of the demands are required. Robotic alternatives have been favorable to both the patient and provider because they offer better or improved alignment, lower times of recovery, and fewer complications. There is growing dependence on robotic assistance in alleviating the rising burden of orthopedic disorders, thus attaining a wider footprint in the global market.

For instance, according to Australian Institute of Health and Welfare 2024, In 2023, the musculoskeletal conditions disease group accounted for 12.8% of total disease burden, 23.1% of non-fatal burden, and 0.8% of fatal burden. It was the second leading disease group contributing to non-fatal burden after mental health conditions and substance use disorders. Back problems were the leading cause of non-fatal burden, accounting for 7.9% of YLD. Within the musculoskeletal conditions disease group, back problems accounted for 34% of burden, followed by other musculoskeletal conditions at 30%, osteoarthritis at 20%, and rheumatoid arthritis at 16%.

High Cost of Robots

The global orthopedic surgical robots market is shaped by the high cost of these advanced systems, which can cost between $5,500 and over $10,000. These systems, which offer precision, reduced recovery times, and improved surgical outcomes, are expensive to implement, especially in smaller hospitals and developing regions. However, this financial barrier presents opportunities for innovation, such as developing cost-effective robotic systems or flexible financing models, which could broaden access and drive market growth.

Segment Analysis

The global orthopedic surgical robots market is segmented based on product type, application, end user and region.

Product type:

Systems segment is expected to dominate the orthopedic surgical robots market share

The systems segment holds a major portion of the orthopedic surgical robots market share and is expected to continue to hold a significant portion of the orthopedic surgical robots market share during the forecast period.

Orthopedic surgical systems are revolutionizing the global market by providing precise alignment, accurate bone resection, and improved implant placement in procedures like joint replacements and spine surgeries. These systems, equipped with advanced imaging, navigation, and robotic-assisted technologies, minimize human error, enhance surgical consistency, and contribute to better patient outcomes, reduced complications, and faster recovery times. As technological advancements continue, orthopedic surgical systems are expected to remain at the forefront of innovation, driving market growth by offering enhanced capabilities tailored to complex orthopedic procedures.

For instance, in October 2024, Aradhana Orthopedic Hospital in Shivamogga has introduced the region's first fully automatic robotic system for knee replacement surgeries, led by Dr. Girish Kumar K., MBBS, MS. This technology offers precision, efficiency, and quicker recovery times for patients undergoing knee replacement surgeries.

Application:

Spine Surgery segment is the fastest-growing segment in orthopedic surgical robots market share

The spine surgery segment is the fastest-growing segment in the orthopedic surgical robots market share and is expected to hold the market share over the forecast period.

Spine surgery is driving the global orthopedic surgical robots market growth, as robotic systems improve precision and safety in complex procedures like spinal fusions and decompressions. Advanced imaging and navigation technologies create accurate surgical plans, reducing complications and improving patient outcomes. The demand for robotic assistance in spine surgeries is driven by the increasing prevalence of spinal disorders, an aging population, and awareness of minimally invasive techniques. Robotic systems are reshaping the spine surgery landscape, making them a key segment in the orthopedic surgical robots market.

For instance, in August 2024, Johnson & Johnson MedTech has announced the launch of the VELYS Active Robotic-Assisted System (VELYS SPINE), a dual-use robotics and standalone navigation platform developed in collaboration with eCential Robotics. The system, which has received FDA clearance, is intended for spinal fusion procedures in the cervical, thoracolumbar, and sacroiliac spine. The dual-use system offers surgeons flexibility in their approach and plans, with active robotics allowing for surgical guidance tailored to their preferences. The unique features of active robotics technology are expected to set a new standard in spine surgical care.

Geographical Analysis

North America is expected to hold a significant position in the orthopedic surgical robots market share

North America holds a substantial position in the orthopaedic surgical robots' market and is expected to hold most of the market share.

North America is a major player in the global orthopaedic surgical robots' market due to technological advancements, robust healthcare infrastructure, and substantial financial investments. The region's network of hospitals and surgical centers prioritizes cutting-edge technologies, leading to widespread acceptance of robotic-assisted surgeries for joint replacements and spine surgeries. The high prevalence of musculoskeletal disorders, such as osteoarthritis and degenerative spine conditions, further fuels the demand for robotic-assisted surgeries.

Moreover, North America's leading manufacturers and innovators in robotic surgery systems drive the market forward, while favourable reimbursement policies and ongoing training of surgeons contribute to its dominance. The trend towards minimally invasive surgeries ensures the continued growth of orthopaedic surgical robots in the region.

For instance, in November 2024, THINK Surgical has received FDA clearance for its TMINI Miniature Robotic System, which is used with LinkSymphoKnee from Waldemar Link GmbH & Co. KG, Germany, under a collaboration agreement. The LinkSymphoKnee is part of THINK Surgical's ID-HUB, a proprietary data bank for the open platform version of its TMINI System in the US.

Europe is growing at the fastest pace in the orthopedic surgical robots market

Europe holds the fastest pace in the orthopaedic surgical robots market and is expected to hold most of the market share.

Europe is a key player in the global orthopaedic surgical robots' market, driven by advanced healthcare systems, innovative technologies, and a focus on surgical precision. The region's supportive regulatory framework and reimbursement structures encourage the integration of robotics in surgical procedures. The aging population, more susceptible to orthopaedic conditions like osteoporosis and joint degeneration, drives the demand for surgical interventions. European healthcare providers are investing in robotic systems to enhance accuracy, reduce complications, and meet minimally invasive procedures. Countries like Germany, the UK, and France are leading the charge, with high adoption rates of robotic-assisted surgeries.

For instance, in September 2024, ZEISS Medical Technology has introduced the KINEVO 900 S, a new Robotic Visualization System, which enhances the clarity of complex surgical procedures in neurosurgery and other surgical disciplines, incorporating advanced digital visualization, collaborative assistant functions, and connected intelligence.

Moreover, in October 2024, Hospital Clinic Barcelona has performed 530 robotic knee replacement surgeries in three and a half years, using the ROSA robot developed by Zimmer and the Smith Nephew CORI Surgical System in 2022. This technological advancement enhances precision, safety, and patient recovery, making it the most performed hospital in Spain. The hospital's use of robotic surgery has minimized risks.

Competitive Landscape

The major global players in the orthopedic surgical robots market include Ekso Bionics, Intuitive Surgical, Medtronic, Stryker Corporation, Smith & Nephew, Wright Medical Group N. V, Zimmer Biomet, General Electric, Think Surgical Inc, Omni among others.

Emerging Players

The emerging players in the orthopedic surgical robots market include Adamis Robotics, OMNIlife Science, Inc, Medicaroid Corporation, Monogram Orthopedics and among others

Key Developments

In February 2024, Sheikh Shakhbout Medical City, a joint venture between Abu Dhabi Health Services Company and Mayo Clinic, has successfully utilized advanced robotic technology for complex surgical procedures, specifically targeting chronic knee pain and a range of osteoarthritic conditions, considering the unique knee's motion and structure.
In August 2023, Stryker has launched a direct patient marketing campaign to improve patient engagement and education about their innovative medical solutions, particularly joint replacement procedures. The campaign aims to empower individuals to make informed decisions about their healthcare, ultimately improving their overall experience and outcomes.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global orthopedic surgical robots market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Orthopedic Disorders
4.2. Restraints
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Systems*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Instruments & Accessories

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Spine Surgery*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Knee Surgery
7.4. Hip Surgery
7.5. Trauma and Fracture Surgery
7.6. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Orthopedic Clinics
8.4. Ambulatory Surgical Centers

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Ekso Bionics*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Intuitive Surgical
11.3. Medtronic
11.4. Stryker Corporation
11.5. Smith & Nephew
11.6. Wright Medical Group N. V
11.7. Zimmer Biomet
11.8. General Electric
11.9. Think Surgical Inc
11.10. Omni

LIST NOT EXHAUSTIVE